ELIZABETH WILLIAMS: Open Payments
NPI 1205844537 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,216 in 161 payments from 27 companies in 2025. Trend: 2023 $4,271 · 2024 $3,861 · 2025 $4,216
Food & beverage: $4,216
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $690 |
| Axsome Therapeutics, Inc. | 12 | $474 |
| PFIZER INC. | 21 | $372 |
| UCB, Inc. | 12 | $368 |
| ACADIA Pharmaceuticals Inc | 8 | $350 |
| SK Life Science, Inc. | 11 | $313 |
| Lundbeck LLC | 15 | $246 |
| ARGENX US, INC. | 8 | $209 |
| Merz Pharmaceuticals, LLC | 7 | $207 |
| Neurocrine BioSciences, Inc. | 7 | $200 |
Products named: NUPLAZID, NURTEC ODT, BOTOX, Nayzilam, Auvelity, Symbravo, VYVGART HYTRULO, Xeomin.
Industry payments across MS — which companies pay providers there.
